Viprey, Virginie F <br/><br/>
Neuroblastoma mRNAs predict outcome in children with stage 4 neuroblastoma: a European HR-NBL1/SIOPEN study.  [electronic resource] 

 -  Journal of clinical oncology : official journal of the American Society of Clinical Oncology  Apr 2014 
 - 1074-83 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1527-7755 
<br/><br/><label>Standard No.: </label>10.1200/JCO.2013.53.3604  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Biomarkers, Tumor--blood<br/>Bone Marrow--metabolism<br/>Carboplatin--administration & dosage<br/>Child<br/>Child, Preschool<br/>Cisplatin--administration & dosage<br/>Computer Simulation<br/>Cyclophosphamide--administration & dosage<br/>Disease-Free Survival<br/>Doublecortin Domain Proteins<br/>Doublecortin Protein<br/>Etoposide--administration & dosage<br/>Homeodomain Proteins--genetics<br/>Humans<br/>Induction Chemotherapy<br/>Infant<br/>Kaplan-Meier Estimate<br/>Microtubule-Associated Proteins--genetics<br/>Neuroblastoma--drug therapy<br/>Neuropeptides--genetics<br/>Predictive Value of Tests<br/>Proportional Hazards Models<br/>RNA, Messenger--blood<br/>Reverse Transcriptase Polymerase Chain Reaction<br/>Survival Rate<br/>Transcription Factors--genetics<br/>Tyrosine 3-Monooxygenase--genetics<br/>Vincristine--administration & dosage